Renee Wu

5PUBLICATIONS
30CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Signal transductionInnate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 11, 2023
IL-6 selectively suppresses cDC1 specification via C/EBPβ.

Sunkyung Kim, Jing Chen, Suin Jo

|Jun 01, 2022
cDC1 Vaccines Drive Tumor Rejection by Direct Presentation Independently of Host cDC1.

Stephen T Ferris, Ray A Ohara, Feiya Ou

|May 11, 2022
DCs at the center of help: Origins and evolution of the three-cell-type hypothesis.

Renee Wu, Kenneth M Murphy

|Jun 17, 2021
<i>Bcl6</i>-Independent In Vivo Development of Functional Type 1 Classical Dendritic Cells Supporting Tumor Rejection.

Prachi Bagadia, Kevin W O'Connor, Renee Wu

|Dec 03, 2017
Migratory CD11b<sup>+</sup> conventional dendritic cells induce T follicular helper cell-dependent antibody responses.

Jayendra Kumar Krishnaswamy, Uthaman Gowthaman, Biyan Zhang

Pageof 1